![]()
fool | Taysha Gene Therapies, Inc. Q2 2021 Earnings Call Transcript |
yahoo | Taysha Gene Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update - Yahoo Finance |
yahoo | Taysha Gene Therapies to Participate in Upcoming June Investor Healthcare Conferences |
yahoo | Taysha Gene Therapies Joins the Rare Disease Company Coalition |
yahoo | Taysha Gene Therapies Expands Leadership Team with the Appointment of Chief Development Officer - Yahoo Finance |
yahoo | Taysha Gene Therapies to Participate in Upcoming May Investor Healthcare Conferences |
fool | Taysha Gene Therapies, Inc. Q1 2021 Earnings Call Transcript |
yahoo | Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update |
yahoo | Taysha Gene Therapies Announces Publication of Preclinical Data for TSHA-102 in Rett Syndrome in Brain, a Highly Esteemed Neurological Science Peer-Reviewed Journal |
apnews | Taysha Gene Therapies Announces New Data on Multiple Preclinical Programs and Upcoming R&D Day |
yahoo | Taysha Gene Therapies Acquires Exclusive Worldwide Rights to Clinical-Stage AAV9 Gene Therapy Program, Now Known as TSHA-120, for the Treatment of Giant Axonal Neuropathy, a Rare and Severe Neurodegenerative Disease |
fool | Taysha Gene Therapies Inc. Q4 2020 Earnings Call Transcript |
yahoo | Taysha Gene Therapies Announces Participation in Upcoming March Investor Healthcare Conferences |
yahoo | Taysha Gene Therapies Reports Full-Year 2020 Financial Results and Provides a Corporate Update |
yahoo | Taysha Gene Therapies Highlights Strategic Priorities and Provides 2021 Business Outlook |
yahoo | Taysha Gene Therapies Continues to Add Significant Gene Therapy Expertise to Leadership Team with the Appointment of Chief Legal Officer and Chief People Officer |
yahoo | Taysha Gene Therapies Receives Rare Pediatric Disease and Orphan Drug Designations for TSHA-105 for the Treatment of Epilepsy Caused by SLC13A5 Deficiency |
digitaljournal | Taysha Gene Therapies and UT Southwestern Medical Center Launch Innovation Fund to Accelerate Advancement of AAV Gene Therapies for Monogenic Diseases of the Central Nervous System |
yahoo | Taysha Gene Therapies Announces Collaboration with AllStripes on SURF1-Associated Leigh Syndrome Clinical Development and Natural History |
yahoo | Taysha Gene Therapies Expands Leadership Team to Deepen Manufacturing and Communications Capabilities |
business.itbusinessnet | Taysha Gene Therapies Announces Queen’s University’s Receipt of Clinical Trial Application Approval from Health Canada for Phase 1/2 Clinical Trial of TSHA-101 for the Treatment of Infantile GM2 Gangliosidosis |
